{"id":"W2332561578","doi":"10.1158/1538-7445.am2011-2242","title":"Abstract 2242: A randomized phase 2 study of the cyclin-dependent kinase (CDK) inhibitor Dinaciclib (SCH 727965) in patients with non-small cell lung cancer (NSCLC)","year":2011,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation; Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Erlotinib; Internal medicine; Oncology; Lung cancer; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001863029,0.00203667,0.002254048,0.0004515921,0.0004407413,0.000993715,0.0007290961,0.001360883,0.005351661],"category_scores_gemma":[0.001583057,0.0009414784,0.001337824,0.0003118657,0.0009715863,0.0008565345,0.0004434986,0.002668406,0.0009595234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009543324,"about_ca_system_score_gemma":0.001786736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001032446,"about_ca_topic_score_gemma":0.002858514,"domain_scores_codex":[0.999265,0.0004614754,0.00003247332,0.00009402778,0.00004660292,0.000100345],"domain_scores_gemma":[0.9992815,0.0001677509,0.0001216641,0.00006118442,0.00005544108,0.0003126498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.956158,0.02289144,0.0009779992,0.0002946409,0.0004817842,0.00006235785,0.00004204654,0.0004442899,0.005967584,0.0001014723,0.0009103249,0.01166802],"study_design_scores_gemma":[0.8874476,0.1096056,0.001325076,0.000007749107,0.0001829509,0.00002623417,0.00001125662,0.0003840122,0.0004231774,0.00007305167,0.0005030502,0.00001030706],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9830293,0.001215057,0.0007523533,0.000702613,0.000398785,0.01012423,0.00140521,0.000130219,0.002242247],"genre_scores_gemma":[0.9787846,0.001049977,0.002210129,0.001467611,0.0004266833,0.009745632,0.001656553,0.00003347825,0.00462531],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005351661,"threshold_uncertainty_score":0.01790309,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04515505282875971,"score_gpt":0.3741909476857539,"score_spread":0.3290358948569942,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}